GlassScriptPhysician profile
Richard Blumrick
NPI 1114982394
$1,355.63
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $108 · 2021: $104 · 2022: $212 · 2023: $187 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $319.91 | 2019-2020 | |
| Abbvie INC. | $183.15 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $119.11 | 2022-2024 | |
| Therapeuticsmd, INC. | $83.74 | 2019-2021 | |
| Myriad Women'S Health, INC. | $75.60 | 2023 | Myrisk |
| Shield Therapeutics INC | $65.95 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.74 | 2019-2023 | |
| Myovant Sciences INC. | $56.81 | 2022 | |
| Hologic Sales and Service, LLC | $54.03 | 2019-2022 | |
| Daiichi Sankyo INC. | $46.18 | 2021-2022 | |
| Boston Scientific Corporation | $41.42 | 2019 | |
| Smith+Nephew, INC. | $31.52 | 2021-2024 | Pico 14, Pico 7, Acticoat 4" X 4" |
| Mylan Pharmaceuticals INC. | $28.26 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $24.61 | 2019 | |
| Roche Diagnostics Corporation | $21.45 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $17.69 | 2022 | |
| Covidien LP | $17.37 | 2019 | |
| Evofem Biosciences, INC. | $17.35 | 2021 | |
| Exeltis, USA INC. | $17.07 | 2020 | |
| Sage Therapeutics, LLC | $16.64 | 2019 | |
| Pfizer INC. | $15.62 | 2022 | |
| Organon LLC | $15.25 | 2022 | |
| Astellas Pharma US INC | $14.87 | 2024 | Veozah |
| Ethicon US, LLC | $14.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Blumrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.